Literature DB >> 22813348

Cortical excitability decreases in Lennox-Gastaut syndrome.

Radwa A B Badawy1, Richard A L Macdonell, Simon J Vogrin, Alan Lai, Mark J Cook.   

Abstract

PURPOSE: We used transcranial magnetic stimulation (TMS) to investigate cortical excitability changes in Lennox-Gastaut syndrome (LGS), anticipating we would find a marked increase in excitability compared to other patients with refractory epilepsies.
METHODS: Eighteen patients with LGS were studied. Motor threshold (MT), short intracortical inhibition (paired pulse TMS at 2 and 5 msec interstimulus intervals [ISIs]), intracortical facilitation (10 and 15 msec ISIs), and long intracortical inhibition (100-300 msec ISIs) were measured. Results were compared to those of 20 patients with chronic refractory idiopathic generalized epilepsy (IGE), 20 patients with chronic refractory focal epilepsy, and 20 healthy nonepilepsy controls. KEY
FINDINGS: A significant decrease in cortical excitability was observed in LGS compared to the other two groups with refractory epilepsy as evidenced by increased MT and intracortical inhibition at both short (2, 5 msec ISIs), and long (100-300 msec ISIs) as well as decreased intracortical facilitation (10, 15 msec ISIs), (p < 0.01; effect sizes ranging from 0.3 to 1.8). Cortical excitability was also lower in LGS compared to nonepilepsy controls (increased MT and decreased intracortical facilitation; p < 0.05; effect sizes ranging from 0.5 to 0.9). SIGNIFICANCE: Interictal cortical excitability is decreased in LGS; a feature that distinguishes it from other refractory epilepsy syndromes. This decrease may be an important mechanism for the neurobehavioral comorbidities associated with LGS. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 22813348     DOI: 10.1111/j.1528-1167.2012.03599.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  4 in total

1.  Transcranial magnetic stimulation as a biomarker for epilepsy.

Authors:  Prisca R Bauer; Annika A de Goede; Esther M Ter Braack; Michel J A M van Putten; Richard D Gill; Josemir W Sander
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

2.  Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.

Authors:  Sophie Dupont; Raluca Banica-Wolters; Isabelle An-Gourfinkel; Virginie Lambrecq; Vincent Navarro; Claude Adam; Vi-Huong Nguyen-Michel
Journal:  J Neurol       Date:  2017-06-05       Impact factor: 4.849

3.  Biomarkers Obtained by Transcranial Magnetic Stimulation of the Motor Cortex in Epilepsy.

Authors:  Melissa Tsuboyama; Harper Lee Kaye; Alexander Rotenberg
Journal:  Front Integr Neurosci       Date:  2019-10-30

4.  Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome: A Pilot Study.

Authors:  Narong Auvichayapat; Katenipa Sinsupan; Orathai Tunkamnerdthai; Paradee Auvichayapat
Journal:  Front Neurol       Date:  2016-05-04       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.